Keystone Heart is focused on protecting the brain from emboli to reduce the risk of brain infarcts during TAVR, atrial fibrillation ablation and other structural heart procedures.

Latest News

Share this
Featured
heart valve replacement surgery

PinnacleHealth Only Hospital in Pennsylvania Enrolling Patients in Clinical Study

Harrisburg, PA – April 5, 2017 – One of the most common, and most serious, heart valve diseases is aortic stenosis. Left untreated, aortic stenosis gradually diminishes quality of life and leads to heart failure and death. The gold standard for treating aortic stenosis has been surgical aortic valve replacement; however, changes in cardiovascular medicine have led to a minimally invasive, catheter-based procedure called transcatheter aortic valve replacement, or TAVR, for patients deemed too high risk for surgery. Patients having either type of aortic valve replacement are at risk of brain injury that may range from memory loss and speech challenges to debilitating strokes. Through a clinical trial, patients at PinnacleHealth have access to an investigational device designed to reduce risk of stroke during TAVR.

This international clinical trial, called REFLECT, studies the safety and efficacy of the Keystone Heart TriGuard™ cerebral embolic protection device to minimize the risk of cerebral damage during TAVR and other cardiovascular procedures.

Read the rest of the press release here.

No Comments

Leave a reply